We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.8B
AUM Growth
-$877M
Cap. Flow
-$1.07B
Cap. Flow %
-18.41%
Top 10 Hldgs %
67.63%
Holding
285
New
60
Increased
42
Reduced
77
Closed
80

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$31.9M
2
GEHC icon
GE HealthCare
GEHC
+$31.5M
3
IBRX icon
ImmunityBio
IBRX
+$20.9M
4
GTLB icon
GitLab
GTLB
+$14.8M
5
VSTM icon
Verastem
VSTM
+$13.4M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$52.3M
2
SPB icon
Spectrum Brands
SPB
+$49.4M
3
SMPL icon
Simply Good Foods
SMPL
+$46.6M
4
SAM icon
Boston Beer
SAM
+$42M
5
DPZ icon
Domino's
DPZ
+$41.4M

Sector Composition

Rank Sector Weight
1 Healthcare 31.42%
2 Consumer Discretionary 5.85%
3 Technology 4.99%
4 Consumer Staples 1.48%
5 Communication Services 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMS icon
176
Maximus
MMS
$3.27B
$256K ﹤0.01%
+3,643
New +$256K
MNST icon
177
Monster Beverage
MNST
$91.5B
$250K ﹤0.01%
+3,997
New +$244K
MO icon
178
Altria Group
MO
$114B
$247K ﹤0.01%
+4,216
New +$248K
TSN icon
179
Tyson Foods
TSN
$21B
$239K ﹤0.01%
+4,264
New +$245K
AEMD icon
180
Aethlon Medical
AEMD
$1.76M
$222K ﹤0.01%
18,500
+651
+4% +$17.5K
AWR icon
181
American States Water
AWR
$3.32B
$218K ﹤0.01%
+2,850
New +$224K
DRMA icon
182
Dermata Therapeutics
DRMA
$4.3M
$188K ﹤0.01%
32,218
-8,882
-22% -$68.1K
CLDI icon
183
Calidi Biotherapeutics
CLDI
$2.03M
$182K ﹤0.01%
4,125
-13,177
-76% -$1.02M
OTRK
184
DELISTED
Ontrak
OTRK
$178K ﹤0.01%
+356,666
New +$517K
BEATW icon
185
Heartbeam Inc Warrant
BEATW
$160K ﹤0.01%
500,000
– –
NXGLW icon
186
NexGel Inc Warrant
NXGLW
$138K ﹤0.01%
550,000
– –
LCFYW icon
187
Locafy Ltd Warrant
LCFYW
$363K
$126K ﹤0.01%
12,121
– –
IVP
188
DELISTED
Inspire Veterinary Partners
IVP
$101K ﹤0.01%
60,000
-142,896
-70% -$226K
MOBBW
189
Mobilicom Ltd Warrants
MOBBW
$1.99B
$89.6K ﹤0.01%
242,100
– –
MDCXW
190
Medicus Pharma Warrant
MDCXW
$493K
$53.5K ﹤0.01%
60,600
– –
ONFOW icon
191
Onfolio Holdings Warrant
ONFOW
$73.9K
$51.9K ﹤0.01%
400,000
– –
NXTC icon
192
NextCure
NXTC
$17.9M
$47.8K ﹤0.01%
8,667
– –
FGIWW
193
FGI Industries Warrant
FGIWW
$180K
$41K ﹤0.01%
933,333
– –
BIAFW icon
194
bioAffinity Technologies
BIAFW
$150K
$26.5K ﹤0.01%
204,082
– –
NXLIW
195
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$15.4K ﹤0.01%
325,000
– –
SWAGW icon
196
Stran & Company Warrant
SWAGW
$12.7K ﹤0.01%
545,000
– –
RVSNW icon
197
Rail Vision Ltd Warrant
RVSNW
$649K
$9.55K ﹤0.01%
136,187
– –
SQFTW icon
198
Presidio Property Trust Inc Series A Warrants
SQFTW
$203K
$6.74K ﹤0.01%
200,000
-1,800,000
-90% -$63K
IVDAW icon
199
Iveda Solutions Warrant
IVDAW
$53.9K
$2.36K ﹤0.01%
18,125
– –
BNCWW
200
CEA Industries Inc Warrant
BNCWW
$2.16K ﹤0.01%
58,333
– –
6 7
8
9 10

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Armistice Capital held 285 positions worth $5.8B, down 13% from $6.67B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Armistice Capital withdrew a net $1.07B in Q2 2025, closing 80 positions and reducing 77 holdings. Its most notable exit was Spectrum Brands, an estimated $49.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Armistice Capital opened a new position in ImmunityBio worth $20.5M.

  • Armistice Capital's largest Q2 2025 buy was ImmunityBio: 7,764,000 shares worth $20.5M.
  • Armistice Capital added most to McDonald's in Q2 2025, an estimated $31.9M increase.
  • Armistice Capital's biggest Q2 2025 reduction was Exact Sciences, cutting an estimated $52.3M.
  • Armistice Capital fully exited Spectrum Brands in Q2 2025, selling an estimated $49.4M.
  • Armistice Capital's ten largest holdings make up 68% of its $5.8B portfolio in Q2 2025.
  • Armistice Capital opened 60 new positions and closed 80 in Q2 2025.
  • Armistice Capital's portfolio value fell 13% quarter-over-quarter to $5.8B.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.